Novo Nordisk A/S

    Jurisdiction
    Denmark
    LEI
    549300DAQ1CVT6CXN342
    ISIN
    US6701002056 (NVO)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    65 / 100
    Better than peer group:
    58 / 100
    Fair value (Benjamin Graham formula)
    €62.90 24.3% undervalued
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    6 / 7

    Profile

    Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. Read full profile

    Fundamentals

    Net revenue
    €41.79B
    Gross margin
    83.9%
    EBIT
    €19.14B
    EBIT margin
    45.8%
    Net income
    €14.88B
    Net margin
    35.6%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €44.99B +7.7% €15.27B +2.6%
    €48.44B +7.7% €16.38B +7.3%
    €51.89B +7.1% €18.39B +12.3%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.58
    Ex date
    Payment date
    Dividend payout ratio
    45.6%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Congress transactions

    Name Transaction date Value
    Val Hoyle September 12, 2025 $1.00K–$15.00K
    Lisa McClain September 12, 2025 $1.00K–$15.00K
    Marjorie Greene August 29, 2025 $1.00K–$15.00K
    Marjorie Greene August 20, 2025 $15.00K–$50.00K
    Scott Franklin August 14, 2025 $16.00K–$65.00K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 6.8M $473.68M -1.5M Sell
    James Anderson 176 $12.22K +123 Buy

    Earnings Calls

    Latest earnings call: May 3, 2024 (Q1 2024)

    Add to watchlist

    Notifications